Future Horizons in the US Blood Banking Market: SupplierShares and Sales Forecasts for 40 Typing, Grouping andScreening Te...
Table of ContentsWorldwide Technology and Market OverviewA. Major Blood Typing, Grouping and Infectious Disease Screening ...
Virus IsolationSerologyDetection of Viral Nucleic Acid or AntigensEpidemiologyWorldwide Spread of AIDSUnited StatesRoutes ...
Clinical FindingsLaboratory FeaturesHepatitis AHepatitis BHepatitis CHepatitis DHepatitis EVirus-Host Immune ReactionsEpid...
g. Creutzfeldt-Jakobfs DiseaseBackgroundTransmissionDiagnostic TestsMajor Commercial and Academic PlayersBayerDisease Scie...
1. Molecular Diagnosticsa. Overviewb. NAT2. Monoclonal and Polyclonal Antibodies3. Immunoassaysa. Technological Principleb...
7. Admissions8. Length of Stay9. Industry Diversification10. Physician Demographics11. Population Aginga. Chronic Illnesse...
DiagastDiaSorinFujirebioGen-ProbeGrifolsImmucorInnogeneticsOrtho-Clinical DiagnosticsOrchid CellMarkNovartis DiagnosticsPr...
U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume ForecastU.S.A., All Market Segments Infectious Disease ...
Upcoming SlideShare
Loading in …5
×

Future Horizons in the US Blood Banking Market: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests by Market Segment

193 views
173 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
193
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Future Horizons in the US Blood Banking Market: Supplier Shares and Sales Forecasts for 40 Typing, Grouping and Screening Tests by Market Segment

  1. 1. Future Horizons in the US Blood Banking Market: SupplierShares and Sales Forecasts for 40 Typing, Grouping andScreening Tests by Market SegmentReport Details:Published:August 2012No. of Pages: 460Price: Single User License – US$8900This report presents a comprehensive analysis of the US blood banking market, including:•Major issues pertaining to the US blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues.•Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, hospitals, commercial laboratories, and plasma fractionation facilities.•Annual placements and installed base estimates for major automated and semiautomated analyzers.•Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.•Ten-year reagent and instrument sales forecasts.•Sales and market shares of leading reagent and instrument suppliers.•Review of current and emerging technologies, and their potential market applications.•Product development opportunities for instruments ,consumables, and auxiliary products.•Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.•Business opportunities and strategic recommendations for suppliers.Contains: 460 pages and 53 tables.Get your copy of this report @http://www.reportsnreports.com/reports/189040-future-horizons-in-the-us-blood-banking-market-supplier-shares-and-sales-forecasts-for-40-typing-grouping-and-screening-tests-by-market-segment.htmlMajor points covered in Table of Contents of this report include
  2. 2. Table of ContentsWorldwide Technology and Market OverviewA. Major Blood Typing, Grouping and Infectious Disease Screening Tests1. Blood Typing and Grouping Testsa. ABOb. Antibody Panelsc. Antibody Screeningd. Antigen Typinge. Antiglobulin Testf. Crossmatchg. HLA Typingh. Rhi. Other Blood Groups2. Infectious Disease Screening Testsa. AIDSStructure and CompositionClassificationOrigin of AIDSAnimal Lentivirus SystemsVirus ReceptorsHIV Infections in HumansPathogenesis & PathologyOverview of Course of HIV InfectionCD4T Lymphocytes and Memory CellsMonocytes and MacrophagesLymphoid OrgansNeural CellsViral CoinfectionsClinical FindingsPlasma Viral LoadPediactric AIDSNeurologic DiseaseOpportunistic InfectionsProtozoaFungiBacteriaVirusesCancerImmunityLaboratory Diagnosis
  3. 3. Virus IsolationSerologyDetection of Viral Nucleic Acid or AntigensEpidemiologyWorldwide Spread of AIDSUnited StatesRoutes of TransmissionPrevention, Treatment, and ControlAntiviral DrugsVaccines Against HIVTransmission of HIV in Blood ProductsHIV Transmission in Transplant and Artificial Insemination RecipientsDiagnostic TestsEnzyme Immunoassay InterpretationSpecificity, Sensitivity, and Predictive Value of Enzyme ImmunoassayCompetition AssaysWestern Blot TechniqueImmuno-Fluorescence Assay (IFA)RadioimmunoprecipitationHIV-1/HIV-2 Combination TestingMethods of HIV-Antigen DetectionAntigen Assays and Blood ScreeningUrine TestsDNA ProbesOverviewQuantitative Polymerase Chain Reactionin Situ PCRNeeded ImprovementsViral Load/Drug Resistance TestingGenotype and Phenotype TestingBlood Banking Considerationsb. HepatitisHepatitis AHepatitis BStructure and CompositionReplication of Hepatitis B VirusHepatitis CHepatitis D (Delta Hepatitis)Hepatitis EHepatitis GHepatitis Virus Infections in HumansPathology
  4. 4. Clinical FindingsLaboratory FeaturesHepatitis AHepatitis BHepatitis CHepatitis DHepatitis EVirus-Host Immune ReactionsEpidemiologyHepatitis AHepatitis BHepatitis CHepatitis D (Delta Agent)Vaccines and Drugsc. CytomegalovirusBackgroundChorioretinitisGastrointestinalCentral Nervous System DiseaseDiagnostic TestsVaccines and Drugsd. SyphilisBackgroundDiagnostic TestsVaccines and Drugse. West Nile VirusBackgroundClinical SyndromesDiagnostic TestsVaccines and Drugsf. Parvovirus B19MicrobiologyEpidemiologyClinical SyndromesErythema Infectiosum Slapped (cheek)Adult PolyarthropathyTransient Aplastic CrisisTransient PancytopeniaRed Cell Aplasia in the ImmunocompromisedPerinatal InfectionsDiagnosisTreatment
  5. 5. g. Creutzfeldt-Jakobfs DiseaseBackgroundTransmissionDiagnostic TestsMajor Commercial and Academic PlayersBayerDisease Sciences/BioTec GlobalImperial College School of MedicineOrtho-Clinical DiagnosticsPallProMetic Life SciencesProteome Sciences/IdexxQ-One BiotechSeronoU.S. Agricultural Research ServiceDrugsVaccinesh. Malariai. Chagas Diseasej. Babesiosis3. Pathogen Reduction4. Leukocyte ReductionBackgroundMethodsB. Instrumentation Review: Operating Characteristics, Features and Selling Prices ofLeading Automated and Semiautomated Analyzers Manufactured by:AbbottBeckman Coulter/DanaherBio-RadBioMerieuxGen-ProbeGrifolsImmucorNanosphereOrtho-Clinical DiagnosticsRocheSarstedtSiemensTecanC. Major in Vitro Diagnostic Technologies And Their Potential Applications
  6. 6. 1. Molecular Diagnosticsa. Overviewb. NAT2. Monoclonal and Polyclonal Antibodies3. Immunoassaysa. Technological Principleb. Chemiluminescencec. Enzyme Immunoassays (EIA)OverviewELISAEMITElectrochemicald. Radioimmunoassays (RIA)e. Immunoprecipitationf. Affinity Chromatography4. Microtitration Plates5. IT and Automation6. Lasers7. Robotics8. Synthetic Red Cell Substitutes9. Genetically Engineered Blood Componentsa. Albuminb. Factor VIIIc. Alpha-2 Antiplasmind. Antithrombin IIIe. Factor IXf. Von Willebrands Factorg. Fibrinogenh. t-PA10. Blood Preservation11. Autologous Blood Transfusion/FreezingU.S.A.A. Executive SummaryB. Business Environment1. Overview2. Health Care Expenditures3 Cost Consciousness4. Industry Consolidation5. Managed Care6. Hospitals
  7. 7. 7. Admissions8. Length of Stay9. Industry Diversification10. Physician Demographics11. Population Aginga. Chronic Illnessesb. Disease Incidencec. Susceptibility to Latrogenesisd. Multiple Illness Cases12. Laboratory RegulationsC. Market StructureD. Market Size, Growth and Major Suppliersf Sales and Market Shares for Blood Typing, Groupingand Infectious Disease Screening TestsMajor Product Development OpportunitiesA. Blood Typing and GroupingB. Infectious Disease ScreeningC. AuxiliaryAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsPotential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionCompetitive AssessmentsAbbottBeckman Coulter/DanaherBecton DickinsonBiokitBioMerieuxBio-Rad
  8. 8. DiagastDiaSorinFujirebioGen-ProbeGrifolsImmucorInnogeneticsOrtho-Clinical DiagnosticsOrchid CellMarkNovartis DiagnosticsProteome SciencesRocheSiemensTecanList of TablesMajor Companies Developing or Marketing Blood Typing and Grouping TestsMajor Companies Developing or Marketing HLA Typing TestsMajor Companies Developing or Marketing AIDS TestsMajor Companies Developing or Marketing Hepatitis TestsMajor Companies Developing or Marketing CMV TestsMajor Companies Developing or Marketing Syphilis TestsMajor Companies Developing or Marketing Blood Bank AnalyzersExecutive Summary Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast byTest CategoryU.S.A., Estimated Number of Inpatient and Ambulatory SurgeriesU.S.A., Facilities Performing Blood Bank Tests by Market SegmentU.S.A., Hospital Laboratories Performing Blood Bank Tests by Bed SizeU.S.A., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test VolumeForecastU.S.A., Facilities Collecting Whole Blood And Plasma by Market Forecast SegmentU.S.A., Whole Blood and Plasma Collections By Market Forecast SegmentU.S.A., All Market Segments Blood Typing and Grouping Test Volume by Market ForecastSegmentU.S.A., All Market Segments Blood Typing And Grouping Test Volume ForecastU.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume ForecastU.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test VolumeForecastU.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume ForecastU.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume Forecast
  9. 9. U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume ForecastU.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast By MarketSegmentU.S.A., All Market Segments Infectious Disease Screening Test Volume ForecastU.S.A., Community and Regional Centers Infectious Disease Screening Test Volume ForecastU.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume ForecastU.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume ForecastU.S.A., Military Blood Banks Infectious Disease Screening Test Volume ForecastU.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by MarketSegmentU.S.A., All Market Segments Blood Typing And Grouping Reagent Market Forecast by MarketSegmentU.S.A., Hospital Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major TestU.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent MarketForecast By Major TestU.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast ByMajor TestU.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market Forecast ByMajor TestU.S.A., Military Blood Banks Blood Typing And Grouping Reagent Market Forecast by Major TestU.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market ForecastSegmentU.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market ForecastSegmentU.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market ForecastBy TestU.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market Forecast ByTestU.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market Forecast By TestU.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast By TestU.S.A., Major Suppliers of Blood Typing And Grouping Reagents Estimated Sales And MarketSharesU.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major SupplierU.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major SupplierU.S.A., Hepatitis C Blood Screening Market, Reagent Sales By Major SupplierU.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major SupplierU.S.A., West Nile Virus NAT Market, Reagent Sales by Major SupplierU.S.A., CMV Blood Screening Market, Reagent Sales by Major SupplierU.S.A., Syphilis Blood Screening Market, Reagent Sales by Major SupplierContact: sales@reportsandreports.com for more information.

×